# Study Of The Effects Of Atorvastatin On Cholesterol Levels In Rheumatoid Arthritis Patients Taking CP-690,550

> **NCT01059864** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 111 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** CP-690,550
- **DRUG:** Atorvastatin
- **DRUG:** CP-690,550
- **DRUG:** Atorvastatin Placebo

## Key facts

- **NCT ID:** NCT01059864
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 111 (ACTUAL)
- **Last updated:** 2012-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01059864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01059864, "Study Of The Effects Of Atorvastatin On Cholesterol Levels In Rheumatoid Arthritis Patients Taking CP-690,550". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01059864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*